| Literature DB >> 36002204 |
Pablo Jorge Marcos-Pardo1,2,3, Tomás Abelleira-Lamela4, Raquel Vaquero-Cristobal5,4, Noelia González-Gálvez3,4.
Abstract
OBJETIVES: To analyse the effects of COVID-19 lockdown on mental well-being variables of older women, and to determine the influence of lifestyle and age on such effects. The hypothesis of the study was that all parameters related to mental well-being would worsen in older women during the COVID-19 lockdown.Entities:
Keywords: COVID-19; geriatric medicine; mental health
Mesh:
Year: 2022 PMID: 36002204 PMCID: PMC9412044 DOI: 10.1136/bmjopen-2022-061993
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Flow diagram.
Characteristics of the sample
| Variable | %(n) or M±SD |
| Age (year old) | 62.35±8.15 |
| Height (cm) | 154.70±7.09 |
| Weight (kg) | 72.50±14.02 |
| BMI (weight (kg)/height2) | 30.30±5.50 |
| Marital status | |
| Single | 5.00 (2) |
| Married | 57.50 (23) |
| Separated | 10.00 (4) |
| Widowed | 27.50 (11) |
| Occupation | |
| Full-time worker | 17.50 (7) |
| Part-time worker | 12.50 (5) |
| Unemployed | 17.50 (7) |
| Retired | 52.50 (21) |
| Education level | |
| No education | 12.50 (5) |
| Elementary school | 57.50 (23) |
| High school | 12.50 (5) |
| Bachelor’s degrees or higher | 17.50 (7) |
| Living status | |
| Living with someone | 72.50 (29) |
| Living alone | 27.50 (11) |
| Sitting time during lockdown (min per day) | 385.20±152.66 |
| MVPA during lockdown (min per week) | 340.50±403.95 |
| Active versus inactive (WHO 150 min/week) | |
| Active | 72.50 (29) |
| Inactive | 27.50 (11) |
| MDA classification | |
| No adherence (≤7 points) | 25 (10) |
| Adherence (>7 points) | 75 (30) |
| Lifestyle (active and MDA vs no active or no adherence) | |
| Healthy | 50.00 (20) |
| Unhealthy | 50.00 (20) |
BMI, body mass index; MDA, Mediterranean Diet Adherence; MVPA, moderate-to-vigorous physical activity.;
Effect of lockdown due to the COVID-19 pandemic in older women (n=40) (unadjusted and adjusted by age and living status)
| Unadjusted | Adjusted by age | Adjusted by living status | ||||||||||
| Pre test (M±SD) | Post-test (M±SD) | Difference post pre (M±SD) | P value | 95% CI (Mpost–Mpre) | Difference post–pre (M±SD) | P value | 95% CI (Mpost–Mpre) | Difference post–pre (M±SD) | P value | 95% CI (Mpost–Mpre) | ||
| Satisfaction with live (SWLS) | 19.93±3.38 | 17.68±4.76 | −2.25±0.66 | 0.001 | −3.58 to −0.93 | −2.25±0.66 | 0.001 | −3.58 to −0.93 | −2.25±0.66 | 0.002 | −3.59 to −0.91 | |
| Depression (CESD Scale) | 13.18±8.52 | 20.13±11.29 | 6.95±1.68 | <0.001 | −3.56 to 10.35 | 6.95±1.67 | <0.001 | 3.57 to 10.33 | 6.95±1.69 | <0.001 | 9.527 to 10.37 | |
| Physical Health (SF-36 Scale) | Physical functioning | 82.74±12.66 | 82.14±8.87 | −0.60±1.70 | 0.726 | −4.03 to 2.84 | −0.60±1.696 | 0.725 | −4.03 to ±2.88 | −0.60±1.696 | 0.730 | −7.079 to ±2.88 |
| Role—physical | 89.10±17.95 | 79.81±18.94 | −9.30±3.21 | 0.006 | −15.78 to −2.81 | −9.30±3.18 | 0.006 | −15.839 to ±−2.88 | −9.30±3.15 | 0.005 | −15.67 to ±−2.916 | |
| Bodily pain | 72.03±20.15 | 62.00±22.35 | −10.02±3.29 | 0.004 | −16.68 to −3.37 | −10.02±2.95 | 0.002 | −15.97 to ±−0.95 | −10.02±3.24 | 0.004 | 3.45 to ±16.59 | |
| General health | 73.19±14.65 | 69.29±18.08 | −3.90±2.37 | 0.108 | −8.69 to 0.89 | −3.90±2.36 | 0.108 | −8.76 to ±0.90 | −3.30±2.27 | 0.094 | −8.49 to ±0.69 | |
| Mental Health (SF-36 Scale) | Vitality | 71.05±14.99 | 69.87±14.70 | −1.18±2.18 | 0.592 | −5.58 to 3.23 | −1.21±2.22 | 0.588 | −3.288 to ±5.711 | −1.18±2.13 | 0.584 | −5.48 to ±3.1 |
| Social functioning | 89.23±14.21 | 88.72±21.66 | −0.51±3.62 | 0.888 | −7.84 to 6.81 | −0.51±3.52 | 0.886 | −6.636 to ±7.65 | −0.51±3.50 | 0.884 | −7.608 to ±6.58 | |
| Role—emotional | 91.88±16.61 | 76.50±21.53 | 15.39±3.89 | <0.001 | −23.26 to −7.51 | −15.39±3.83 | <0.001 | 7.52 to ±23.26 | −15.39±3.91 | <0.001 | −23.32 to ±−7.45 | |
| Mental health | 77.78±12.85 | 65.89±14.01 | −11.88±2.10 | <0.001 | −16.12 to −7.64 | −11.88±2.12 | <0.001 | −7.59 to ±16.26 | −11.88±2.12 | <0.001 | −16.18 to ±−7.58 | |
| Sleep (PSQI Scale) | C1 Sleep quality component | 1.11±0.57 | 1.36±0.68 | 0.25±0.10 | 0.018 | 0.05 to 0.45 | 0.25±0.10 | 0.021 | 0.04 to ±0.460 | 0.25±0.10 | 0.019 | 0.43 to ±0.45 |
| C2 Sleep latency | 1.28±1.03 | 1.78±1.17 | 0.50±0.16 | 0.004 | 0.17 to 0.83 | 0.50±0.16 | 0.005 | 0.167 to ±0.834 | 0.50±0.16 | 0.004 | 0.17 to ±0.83 | |
| C3 Sleep duration | 1.00±0.76 | 1.08±0.77 | 0.08±0.11 | 0.446 | −0.14 to 0.30 | 0.08±0.11 | 0.459 | −0.143 to ±0.310 | 0.08±0.11 | 0.446 | −0.14 to ±0.30 | |
| C4 Habitual Sleep efficiency | 0.92±1.11 | 0.81±1.01 | −0.11±0.13 | 0.401 | −0.38 to 0.15 | −0.11±0.13 | 0.396 | −0.37 to ±0.15 | −0.11±0.13 | 0.369 | −0.359 to ±0.14 | |
| C5 Step disturbances | 1.39±0.60 | 1.75±0.60 | 36±0.11 | 0.002 | 0.15 to 0.58 | 0.36±0.11 | 0.002 | 0.141 to ±0.58 | 0.36±0.11 | 0.002 | 0.14 to ±0.58 | |
| C6 Use of sleeping medication | 1.00±1.39 | 1.28±1.47 | 0.28±0.17 | 0.115 | −0.07to 0.63 | 0.28±0.16 | 0.089 | −0.601 to ±0.045 | 0.28±0.17 | 0.116 | 0.08 to ±0.63 | |
| C7 Day time dysfunction | 0.50±0.61 | 0.64±0.59 | 0.14±0.13 | 0.281 | −0.12 to 0.40 | 0.14±0.13 | 0.295 | −0.126 to ±0.404 | 0.14±0.13 | 0.288 | 0.12 to ±0.40 | |
| Global score | 7.19±4.06 | 8.69±3.91 | 1.50±0.46 | 0.002 | 0.57 to 2.43 | 1.50±0.46 | 0.002 | 0.568 to ±2.43 | 1.50±0.46 | 0.003 | 0.56 to ±2.44 | |
C, component; CESD, Centre for Epidemiologic Studies Depression Scale; PSQI, Pittsburgh Sleep Quality Index; SF-36, Short Form 36 Health Survey; SWLS, Satisfaction with Life Scale.
Non-linear multiple regression analysis of the relationship of dependent and independent variables
| R2 | P value | Included independent variables | Standarized coefficient (β) | |
| Depression | 0.116 | 0.031 | Adherence Mediterranean diet | −0.341 |
| Physical role health | 0.224 | 0.002 | Spending time sitting | −0.474 |
| Age | 0.192 | 0.005 | Pain | 0.438 |
| Use of sleeping medication | 0.144 | 0.017 | Unhealthy lifestyle | 0.379 |
Sources of variation, sum of squares, df, mean squares, % and SE
| Design | Sum of squares | DF | Mean squares | % | SE | |
| Satisfaction with live (SWLS Scale) | 90.120 | 156 | 0.578 | 59.583 | 0.065 | |
| Depression (CESD Scale) | 512.376 | 741 | 0.691 | 69.069 | 0.036 | |
| Physical Health (SF-36 Scale) | Physical functioning | 57.413 | 234 | 0.244 | 39.811 | 0.022 |
| Role—physical | 6.931 | 117 | 0.0590 | 33.780 | 0.008 | |
| Bodily pain | 26.888 | 39 | 0.689 | 40.793 | 0.152 | |
| General health | 141.2 | 156 | 0.905 | 67.139 | 0.102 | |
| Mental Health (SF-36 Scale) | Vitality | 82.650 | 117 | 0.706 | 54.059 | 0.092 |
| Social functioning | 12.688 | 390 | 0.325 | 45.373 | 0.072 | |
| Role—emotional | 3.267 | 78 | 0.042 | 30.769 | 0.007 | |
| Mental health | 124.270 | 156 | 0.797 | 60.048 | 0.090 | |
| Sleep (PSQI Scale) | 112.317 | 195 | 0.576 | 60.067 | 0.058 | |
CESD, Center for Epidemiologic Studies Depression; PSQI, Pittsburgh Sleep Quality Index; SF-36, The Short Form 36 Health Survey; SWLS, Satisfaction with Life Scale.
Absolute generalisability coefficient, relative generalisability coefficient, absolute SD and relative SD in each of the designs
| Design | Absolute generalisability coefficient | Relative generalisability coefficient | Absolute SD | Relative SD | |
| Satisfaction with live (SWLS Scale) | 0.734 | 0.748 | 0.353 | 0.340 | |
| Depression (CESD Scale) | 0.778 | 0.812 | 0.206 | 0.186 | |
| Physical Health (SF-36 Scale) | Physical functioning | 0.579 | 0.755 | 0.269 | 0.187 |
| Role—physical | 0.873 | 0.882 | 0.127 | 0.122 | |
| Bodily pain | 0.677 | 0.712 | 0.647 | 0.587 | |
| General health | 0.633 | 0.656 | 0.448 | 0.425 | |
| Mental Health (SF-36 Scale) | Vitality | 0.767 | 0.770 | 0.423 | 0.420 |
| Social functioning | 0.630 | 0.669 | 0.440 | 0.403 | |
| Role—emotional | 0.871 | 0.871 | 0.118 | 0.118 | |
| Mental health | 0.714 | 0.735 | 0.421 | 0.399 | |
| Sleep (PSQI Scale) | 0.782 | 0.789 | 0.316 | 0.310 | |
CESD, Center for Epidemiologic Studies Depression; PSQI, Pittsburgh Sleep Quality Index; SF-36, The Short Form 36 Health Survey; SWLS, Satisfaction with Life Scale.